Skip to content
Login
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Login
Login
Account Settings
Login
Login
Account Settings
Login
Sign Up
Real Clinics. Real Patients. Real Oncology.
Home
/
Topics
/
Genitourinary Cancers
/
Bladder Cancer
Home /
Bladder Cancer
Bladder Cancer
Bladder Cancer
Recent Updates
Researchers Find a Minimally Invasive Option for Recurrent NMIBC
August 10, 2026
Recent Updates
Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC
August 3, 2026
Recent Updates
Immunotherapy Shows Promise in Sparing Cystectomy for High-Risk BCG-Unresponsive NMIBC
July 27, 2026
Recent Updates
Active Surveillance Matches BCG Therapy for Select Patients With High-Grade T1 Bladder Cancer
July 20, 2026
Clinical Trials
New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy
July 14, 2026
Clinical Trials
MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage
July 14, 2026
Clinical Trials
Enfortumab Vedotin Plus Pembrolizumab Combo Shows Promise for Cisplatin-Ineligible Bladder Cancer
June 26, 2026
Recent Updates
Researchers Find a Minimally Invasive Option for Recurrent NMIBC
August 10, 2026
Recent Updates
Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC
August 3, 2026
Recent Updates
Immunotherapy Shows Promise in Sparing Cystectomy for High-Risk BCG-Unresponsive NMIBC
July 27, 2026
Recent Updates
Active Surveillance Matches BCG Therapy for Select Patients With High-Grade T1 Bladder Cancer
July 20, 2026
Clinical Trials
New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy
July 14, 2026
Clinical Trials
MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage
July 14, 2026
Clinical Trials
Enfortumab Vedotin Plus Pembrolizumab Combo Shows Promise for Cisplatin-Ineligible Bladder Cancer
June 26, 2026
News & Insights
Recent Updates
Researchers Find a Minimally Invasive Option for Recurrent NMIBC
August 10, 2026
Recent Updates
Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC
August 3, 2026
Recent Updates
Immunotherapy Shows Promise in Sparing Cystectomy for High-Risk BCG-Unresponsive NMIBC
July 27, 2026
Recent Updates
Active Surveillance Matches BCG Therapy for Select Patients With High-Grade T1 Bladder Cancer
July 20, 2026
Clinical Trials
New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy
July 14, 2026
Clinical Trials
MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage
July 14, 2026
Clinical Trials
Enfortumab Vedotin Plus Pembrolizumab Combo Shows Promise for Cisplatin-Ineligible Bladder Cancer
June 26, 2026
Podcasts
No results were found
What are you looking for?
Search
Search
POPULAR SEARCHES
Bladder Cancer
Blood-Based Tests
Breast Cancer
Cancer Types
